TGTX vs. JPM
TGTX (TG Therapeutics, Inc.) and JPM (JPMorgan Chase & Co.) are both stocks. TGTX operates in Biotechnology (Healthcare), while JPM operates in Banks - Diversified (Financial Services). Over the past 10 years, TGTX returned 22.01%/yr vs 20.94%/yr for JPM. At a 0.20 correlation, their price movements are largely independent.
Performance
TGTX vs. JPM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TGTX achieves a 68.74% return, which is significantly higher than JPM's 0.08% return. Both investments have delivered pretty close results over the past 10 years, with TGTX having a 22.01% annualized return and JPM not far behind at 20.94%.
TGTX
- 1D
- 1.58%
- 1M
- 27.34%
- YTD
- 68.74%
- 6M
- 60.14%
- 1Y
- 39.68%
- 3Y*
- 25.14%
- 5Y*
- 6.51%
- 10Y*
- 22.01%
JPM
- 1D
- -0.41%
- 1M
- 7.25%
- YTD
- 0.08%
- 6M
- 0.77%
- 1Y
- 22.90%
- 3Y*
- 33.65%
- 5Y*
- 18.32%
- 10Y*
- 20.94%
TGTX vs. JPM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TGTX TG Therapeutics, Inc. | 68.74% | -0.96% | 76.23% | 44.38% | -37.74% | -63.48% | 368.65% | 170.73% | -50.00% | 76.34% |
JPM JPMorgan Chase & Co. | 0.08% | 37.27% | 44.29% | 30.63% | -12.64% | 27.75% | -5.53% | 47.26% | -6.62% | 26.76% |
Correlation
The correlation between TGTX and JPM is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since May 3, 2010 | 0.20 |
Fundamentals
TGTX:
$8.05B
JPM:
$892.31B
TGTX:
$2.87
JPM:
$21.08
TGTX:
17.51
JPM:
15.15
TGTX:
0.03
JPM:
1.67
TGTX:
11.55
JPM:
3.13
TGTX:
13.81
JPM:
2.59
TGTX:
$700.35M
JPM:
$285.09B
TGTX:
$581.54M
JPM:
$173.52B
TGTX:
$156.88M
JPM:
$81.46B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TGTX vs. JPM — Risk / Return Rank
TGTX
JPM
TGTX vs. JPM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TGTX | JPM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.21 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.19 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 1.22 | 1.49 | -0.27 |
| Martin ratioReturn relative to average drawdown | 2.21 | 3.51 | -1.30 |
Loading charts...
Drawdowns
TGTX vs. JPM - Drawdown Comparison
The maximum TGTX drawdown since its inception was -99.52%, which is greater than JPM's maximum drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for TGTX and JPM.
Loading charts...
Drawdown Indicators
| TGTX | JPM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.52% | -76.16% | -23.36% |
Max Drawdown (1Y)Largest decline over 1 year | -32.66% | -15.47% | -17.19% |
Max Drawdown (3Y)Largest decline over 3 years | -74.79% | -24.42% | -50.37% |
Max Drawdown (5Y)Largest decline over 5 years | -90.75% | -38.77% | -51.98% |
Max Drawdown (10Y)Largest decline over 10 years | -93.19% | -43.63% | -49.56% |
Current DrawdownCurrent decline from peak | -78.45% | -4.06% | -74.39% |
Average DrawdownAverage peak-to-trough decline | -91.42% | -17.61% | -73.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.03% | 6.54% | +11.49% |
Volatility
TGTX vs. JPM - Volatility Comparison
TG Therapeutics, Inc. (TGTX) has a higher volatility of 14.69% compared to JPMorgan Chase & Co. (JPM) at 6.38%. This indicates that TGTX's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TGTX | JPM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.69% | 6.38% | +8.31% |
Volatility (6M)Calculated over the trailing 6-month period | 34.05% | 16.51% | +17.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.11% | 21.77% | +25.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.80% | 24.44% | +63.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.90% | 27.40% | +59.50% |
Dividends
TGTX vs. JPM - Dividend Comparison
TGTX has not paid dividends to shareholders, while JPM's dividend yield for the trailing twelve months is around 1.85%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JPM JPMorgan Chase & Co. | 1.85% | 1.72% | 1.92% | 2.38% | 2.98% | 2.34% | 2.83% | 2.37% | 2.54% | 1.91% | 2.13% | 2.54% |
TGTX TG Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TGTX vs. JPM - Financials Comparison
This section allows you to compare key financial metrics between TG Therapeutics, Inc. and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TGTX vs. JPM - Profitability Comparison
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.
JPM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a gross profit of 47.33B and revenue of 73.66B. Therefore, the gross margin over that period was 64.3%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.
JPM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported an operating income of 20.48B and revenue of 73.66B, resulting in an operating margin of 27.8%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.
JPM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a net income of 16.49B and revenue of 73.66B, resulting in a net margin of 22.4%.
Frequently Asked Questions
TGTX and JPM have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TGTX has higher volatility (14.69%) compared to JPM (6.38%). In terms of maximum drawdown, TGTX dropped -99.52% vs JPM's -76.16%.
JPM currently has the higher Sharpe Ratio (1.06 vs 0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TGTX and JPM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer